↓ Skip to main content

Hyperbaric oxygen therapy for late radiation tissue injury

Overview of attention for article published in Cochrane database of systematic reviews, May 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter
3 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hyperbaric oxygen therapy for late radiation tissue injury
Published in
Cochrane database of systematic reviews, May 2012
DOI 10.1002/14651858.cd005005.pub3
Pubmed ID
Authors

Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C, Bennett, Michael H, Feldmeier, John, Hampson, Neil, Smee, Robert, Milross, Christopher

Abstract

Cancer is a significant global health problem. Radiotherapy is a treatment for many cancers and about 50% of patients having radiotherapy with be long-term survivors. Some will experience late radiation tissue injury (LRTI) developing months or years later. Hyperbaric oxygen therapy (HBOT) has been suggested as a treatment for LRTI based upon the ability to improve the blood supply to these tissues. It is postulated that HBOT may result in both healing of tissues and the prevention of problems following surgery.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 17%
Student > Doctoral Student 1 17%
Unknown 4 67%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Medicine and Dentistry 1 17%
Unknown 4 67%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2014.
All research outputs
#6,403,505
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#5,425
of 7,978 outputs
Outputs of similar age
#50,613
of 110,938 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 92 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.